A1BG | Alpha-1-B glycoprotein | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
A1CF | APOBEC1 complementation factor | Predicted intracellular proteins
| | | | | Tissue enhanced |
A2M | Alpha-2-macroglobulin | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
A2ML1 | Alpha-2-macroglobulin-like 1 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
A4GNT | Alpha-1,4-N-acetylglucosaminyltransferase | Predicted secreted proteins
| | | | | Tissue enriched |
AAGAB | Alpha- and gamma-adaptin binding protein | Disease related genes Predicted intracellular proteins
| | | | | Expressed in all |
AAK1 | AP2 associated kinase 1 | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
AAMDC | Adipogenesis associated, Mth938 domain containing | Predicted intracellular proteins
| | | | | Expressed in all |
AAMP | Angio-associated, migratory cell protein | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
AARS | Alanyl-tRNA synthetase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
AARS2 | Alanyl-tRNA synthetase 2, mitochondrial | Cancer-related genes Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
AARSD1 | Alanyl-tRNA synthetase domain containing 1 | Predicted intracellular proteins
| | | | | Expressed in all |
AASS | Aminoadipate-semialdehyde synthase | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
AATF | Apoptosis antagonizing transcription factor | Predicted intracellular proteins
| | | | | Expressed in all |
ABAT | 4-aminobutyrate aminotransferase | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
ABCA7 | ATP-binding cassette, sub-family A (ABC1), member 7 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCB11 | ATP-binding cassette, sub-family B (MDR/TAP), member 11 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
ABCB7 | ATP-binding cassette, sub-family B (MDR/TAP), member 7 | Disease related genes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCB8 | ATP-binding cassette, sub-family B (MDR/TAP), member 8 | Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCC1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 | Cancer-related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCC11 | ATP-binding cassette, sub-family C (CFTR/MRP), member 11 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ABCC2 | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 | Cancer-related genes Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
ABCC3 | ATP-binding cassette, sub-family C (CFTR/MRP), member 3 | Cancer-related genes Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Mixed |
ABCC4 | ATP-binding cassette, sub-family C (CFTR/MRP), member 4 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCC5 | ATP-binding cassette, sub-family C (CFTR/MRP), member 5 | Cancer-related genes Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCD2 | ATP-binding cassette, sub-family D (ALD), member 2 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCD3 | ATP-binding cassette, sub-family D (ALD), member 3 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCE1 | ATP-binding cassette, sub-family E (OABP), member 1 | Mitochondrial proteins Predicted intracellular proteins
| | | | | Expressed in all |
ABCF1 | ATP-binding cassette, sub-family F (GCN20), member 1 | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ABCF2 | ATP-binding cassette, sub-family F (GCN20), member 2 | Predicted intracellular proteins
| | | | | Expressed in all |
ABCF3 | ATP-binding cassette, sub-family F (GCN20), member 3 | Predicted intracellular proteins
| | | | | Expressed in all |
ABCG1 | ATP-binding cassette, sub-family G (WHITE), member 1 | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
ABCG2 | ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group) | Cancer-related genes CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ABHD10 | Abhydrolase domain containing 10 | Enzymes Mitochondrial proteins Predicted secreted proteins
| | | | | Expressed in all |
ABHD11 | Abhydrolase domain containing 11 | Disease related genes Predicted intracellular proteins
| | | | | Expressed in all |
ABHD14A-ACY1 | ABHD14A-ACY1 readthrough (NMD candidate) | Predicted intracellular proteins
| | | | | Not detected |
ABHD14B | Abhydrolase domain containing 14B | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ABI1 | Abl-interactor 1 | Cancer-related genes Cytoskeleton related proteins Disease related genes Predicted intracellular proteins
| | | | | Expressed in all |
ABI2 | Abl-interactor 2 | Cytoskeleton related proteins Predicted intracellular proteins
| | | | | Expressed in all |
ABL1 | ABL proto-oncogene 1, non-receptor tyrosine kinase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
ABL2 | ABL proto-oncogene 2, non-receptor tyrosine kinase | Cancer-related genes Enzymes Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
ABLIM1 | Actin binding LIM protein 1 | Predicted intracellular proteins
| | | | | Expressed in all |
ABRACL | ABRA C-terminal like | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ABTB1 | Ankyrin repeat and BTB (POZ) domain containing 1 | Predicted intracellular proteins
| | | | | Expressed in all |
ABTB2 | Ankyrin repeat and BTB (POZ) domain containing 2 | Predicted intracellular proteins
| | | | | Mixed |
AC004381.6 | Putative RNA exonuclease NEF-sp | Predicted intracellular proteins
| | | | | Tissue enriched |
AC009133.22 | Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000404873} | Predicted secreted proteins
| | | | | Tissue enhanced |
ACAA1 | Acetyl-CoA acyltransferase 1 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ACAA2 | Acetyl-CoA acyltransferase 2 | Enzymes Mitochondrial proteins Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ACACA | Acetyl-CoA carboxylase alpha | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |